Fertility testing company Proov announced Tuesday that it has raised $9.7 million in Series A funding.
The round was led by Hambrecht Ducera Growth Ventures with participation from SteelSky Ventures, WCC Partners, LightShip Capital, GingerBread Capital and Portfolia.
WHAT THEY DO
In early 2020, Proov scored FDA clearance for its at-home urine test measuring pregnanediol glucuronide, which can...
At-home fertility test maker Proov is expanding its footprint to Europe after receiving CE marking for its ovulation-confirming test kit.
Proov’s ovulation testing kit got clearance by the FDA for sales in the U.S. last year. The test looks for Pregnanediol Glucuronide (PdG), a metabolite of progesterone produced in urine after ovulation. When elevated levels of PdG are detected in urine, it...
At-home fertility testing startup Modern Fertility has raised $15 million in Series A funding in a round led by Forerunner Ventures and its founding partner, Kirsten Green, who will be joining the company’s board.
WHAT THEY DO
Modern Fertility’s direct-to-consumer business starts when the customer requests a personalized at-home test, or opts to take it at a local lab. Once the results are...
Mira, the women’s health startup that launched last month at TechCrunch disrupt and won a recent startup competition at Health 2.0, has moved fast.
The three-year old company has 36 employees, a device nearly on the market, and FDA and CE Mark clearances. And almost unheard of for a tech startup, it does its own manufacturing.
“We built 11,000 square feet of manufacturing facility ourselves,...
Swiss Precision Diagnostics, a subsidiary of consumer products giant Procter & Gamble which offers the Clearblue fertility test, has released a new version of its testing device with Bluetooth connectivity and a digital app.
"There are lots of fertility apps and we know women like to use these apps," Dr. Fiona Clancy, scientific and medical affairs director at SPD, told MobiHealthNews. "...
